Hypoalbuminemia in children with acute lymphoblastic leukemia: relation to asparaginase therapy and impact on high dose methotrexate elimination
Cancer Chemotherapy and Pharmacology · 2024
DOI: 10.1007/s00280-024-04713-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Sophie Rex Christensen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescence Medicine, Aalborg University Hospital, Reberbansgade, 9000, Aa…. Hauptthemen laut MEDLINE: Hypoalbuminemia, Methotrexate, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Asparaginase. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, National Institute of Child Health and Development T32 Cincinnati Pediatrics Clinical Pharmacology Training Program, Aalborg University Hospital.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
High-dose methotrexate (HDMTX) therapy is an important component in treatment regimens for acute lymphoblastic leukemia (ALL). Courses are associated with a risk of renal injury, delayed elimination, and increased systemic toxicity. Recently hypoalbuminemia has been recognized as yet another risk factor.
Methods
To examine the impact of serum albumin we reviewed 325 HDMTX 5 g/m2 courses in a cohort of 51 children treated on the NOPHO ALL 2008 protocol, dividing the courses into four groups with different levels of baseline albumin (A < 25 g/L, B 25–29 g/L, C 30–34 g/L and D ≥ 35 g/L).
Results
Hypoalbuminemia was present in 51% of the courses, mostly in the early phases of chemotherapy while asparaginase therapy is ongoing, and especially if given less than 2 weeks after a dose (78%). Hypoalbuminemia had a significant impact on the end-of-infusion serum MTX, depending on the degree of hypoalbuminemia: MTX > 150 µM was seen in 37%, 32%, 20% and 8% in groups A to D. Serum albumin < 30 g/L was significantly associated with low MTX clearance < 10 L/h/1.73m2 (78% vs. 36%) and high AUC ≥ 1000 µM*h (44% vs. 31%). The frequency of rising creatinine or prolonged elimination was not increased, but the risk of stomatitis was significantly higher (42% vs. 19%).
Conclusion
Low serum albumin is caused by concurrent asparaginase therapy and has a clinically significant impact on MTX disposition. Guidelines for administering HDMTX may need adjustment if serum albumin < 30 g/L, and, if possible, HDMTX courses should not be scheduled soon after asparaginase doses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescence Medicine, Aalborg University Hospital, Reberbansgade, 9000, Aalborg, Denmark. sophie.c@rn.dk.
- Section of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescence Medicine, Aalborg University Hospital, Reberbansgade, 9000, Aalborg, Denmark.
- Childhood Cancer and Research Unit, University Children's Hospital, Lund, Sweden.
- Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, MO, USA.
ORCID-Profile: Sophie Rex Christensen
Förderung
- NICHD NIH HHS
- National Institute of Child Health and Development T32 Cincinnati Pediatrics Clinical Pharmacology Training Program
- Aalborg University Hospital
Zitieren
APA
Christensen, S. R., Jensen, C. F., Heldrup, J., Taylor, Z., Ramsey, L. B., & Rosthøj, S. (2024). Hypoalbuminemia in children with acute lymphoblastic leukemia: relation to asparaginase therapy and impact on high dose methotrexate elimination. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04713-0
Vancouver
Christensen SR, Jensen CF, Heldrup J, Taylor Z, Ramsey LB, Rosthøj S. Hypoalbuminemia in children with acute lymphoblastic leukemia: relation to asparaginase therapy and impact on high dose methotrexate elimination. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04713-0
BibTeX
@article{Christensen2024,
author = {Christensen, Sophie Rex and Jensen, Christina Friis and Heldrup, Jesper and Taylor, Zachary and Ramsey, Laura B and Rosthøj, Steen},
title = {Hypoalbuminemia in children with acute lymphoblastic leukemia: relation to asparaginase therapy and impact on high dose methotrexate elimination},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2024},
doi = {10.1007/s00280-024-04713-0}
}
EUVIMED